Clinical research company Medpace Holdings (NASDAQ:MEDP) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 7 ...

Medpace (MEDP) came out with quarterly earnings of $3.67 per share, beating the Zacks Consensus Estimate of $2.97 per share. This compares to earnings of $2.46 per share a year ago. These figures ...

In the latest trading session, Medpace (MEDP) closed at $350.37 ... Elsewhere, the Dow gained 0.65%, while the tech-heavy Nasdaq lost 3.07%. Heading into today, shares of the provider of ...

In the latest market close, Medpace (MEDP) reached $343.38 ... At the same time, the Dow lost 0.28%, and the tech-heavy Nasdaq lost 1.2%. The the stock of provider of outsourced clinical ...

MEDPACE HOLDINGS ($MEDP) posted quarterly earnings results on Monday, February 10th. The company reported earnings of $3.67 per share, beating estimates of $3.02 by ...

Rhumbline Advisers lifted its position in Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) by 0.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional ...

Madison Investments, an investment advisor, released its “Madison Small Cap Fund” fourth-quarter 2024 investor letter. A copy ...

Analysts at William Blair raised their Q1 2025 EPS estimates for shares of Medpace in a research note issued to investors on ...

Q4 2024 Earnings Call Transcript February 11, 2025 Operator: And good day, ladies and gentlemen, and welcome to the Medpace ...

Equities research analysts at William Blair decreased their Q3 2025 earnings estimates for Medpace in a research report ...